Showing 1221-1230 of 1635 results for "".
- VSP Global Names Steve Baker President of VSP Ventureshttps://modernod.com/news/vsp-global-names-steve-baker-president-of-vsp-ventures/2476398/VSP Global has announced the appointment of Steve Baker, president of Eyefinity, to lead the newly-established VSP Ventures, according to a report in VisionMonday. “Steve’
- Eyecare Services Partners Names New CEO and Adds Two Other Executiveshttps://modernod.com/news/eyecare-services-partners-names-new-ceo-and-adds-two-other-executives/2476353/Eyecare Services Partners (ESP) has appointed George Neal as chief executive officer, effective March 4. Mr. Neal was previously chief executive officer of Access Dental, a dental services organization that was recently sold by Guardian Life Insurance Company of America, according to a
- Ziemer USA Names Brad Hurt Vice President of Business Developmenthttps://modernod.com/news/ziemer-usa-names-brad-hurt-vice-president-of-business-development/2476263/Ziemer USA announced the appointment of Brad Hurt to its executive US leadership team as Vice President of Business Development. Mr. Hurt joins Ziemer USA from Bausch + Lomb Surgical, where he was most recently Vice President of US Surgical Sales. “I couldn’t be more excited to join the Zi
- SECO International Names J. Max Ernst, OD, as 2020 Presidenthttps://modernod.com/news/seco-international-names-j-max-ernst-od-as-2020-president/2476329/SECO International, the world’s largest educational conference, has announced that J. Max Ernst, OD, will become the next SECO International President. Dr. Ernst will officially accept the honor during the House of Delegates meeting, held during SECO 2019, Saturday, February 23, from 3:15 pm-5 pm
- New National Survey Reveals Greater Risk of Seniors Switching Medicare Advantage Plans in 2019https://modernod.com/news/new-national-survey-reveals-greater-risk-of-seniors-switching-medicare-advantage-plans-in-2019/2476186/A new survey by Welltok validated that today’s seniors are increasingly tech savvy, expect more from Medicare plans, and are striving for total wellbeing. With over 60 million Americans projected to be covered by Medicare by 2020, it is critical for plans to understand and meet members̵
- Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps for ONS-5010 Clinical Strategyhttps://modernod.com/news/oncobiologics-changes-name-to-outlook-therapeutics-announces-next-steps-for-ons-5010-clinical-strategy/2476161/Oncobiologics announced several key corporate events that enhance the company’s ability to advance the development of its lead product candidate, ONS-5010, a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration (AMD). These events are in c
- Acuvue Oasys with Transitions Light Intelligent Technology Named Among TIME’s ‘Best Inventions of 2018’https://modernod.com/news/acuvue-oasys-with-transitions-light-intelligent-technology-named-among-times-best-inventions-of-2018/2479661/TIME has selected Acuvue Oasys with Transitions Light Intelligent Technology as one of the ‘Best Inventions of 2018,’ in its annual round-up spotlighting groundbreaking innovations worldwide. The development of Acuvue Oasys with Transitions has created and defined an entirely new cate
- Prevent Blindness Elects Three New Members to National Board of Directorshttps://modernod.com/news/prevent-blindness-elects-three-new-members-to-national-board-of-directors-2/2479700/Prevent Blindness has announced that Paul Delatore, Global Head, Market Access at Alcon; Jim McGrann, Chairman & CEO of Healthy Eyes Advantage; and Rajeev S. Ramchandran, MD, Associate Professor of Ophthalmology in the University of Rochester Medical School’s Department of Ophthalmology, have
- SemaThera Board Names Garth Cumberlidge as President & CEOhttps://modernod.com/news/semathera-board-names-garth-cumberlidge-as-president-ceo/2479705/SemaThera announced that its board of directors has appointed Garth Cumberlidge as President and Chief Executive Officer. Dr. Cumberlidge was also elected to the board of directors of SemaThera. He will lead the company’s development programs in diabetic macular edema and other degenerative retin
- Neuro-Optometric Rehabilitation Association Names New Members to its Advisory Boardhttps://modernod.com/news/nuero-optometric-rehabilitation-association-names-new-members-to-its-advisory-board/2479836/The Neuro-Optometric Rehabilitation Association, International (NORA) announced the addition of six new members to its Advisory Board, at the Association’s 27th Annual Conference in St. Louis. “Our new Advisory Board members bring a rich mix of backgrounds and experiences that w